Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure.
Two series of symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure were prepared and tested for inhibitory property against the enzyme. All compounds showed weak antiprotease activity.